Your browser doesn't support javascript.
loading
The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model.
Geyer, Marlene; Gaul, Lisa-Marie; D Agosto, Sabrina Luigia; Corbo, Vincenzo; Queiroz, Karla.
Afiliação
  • Geyer M; Mimetas B.V., Oegstgeest, Netherlands.
  • Gaul LM; Mimetas B.V., Oegstgeest, Netherlands.
  • D Agosto SL; Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
  • Corbo V; Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
  • Queiroz K; Mimetas B.V., Oegstgeest, Netherlands.
Front Immunol ; 14: 1155085, 2023.
Article em En | MEDLINE | ID: mdl-37205118
ABSTRACT
The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation of processes underlying the interaction between the tumor stroma, particularly activated pancreatic stellate cells (PSCs), and immune cells may offer new therapeutic approaches for PDAC treatment. In this study, we established a 3D PDAC model cultured under flow, consisting of an endothelial tube, PSCs and PDAC organoids. This was applied to study the role of the tumor microenvironment (TME) on immune cell recruitment and its effect on partly preventing their interaction with pancreatic cancer cells. We observed that stromal cells form a physical barrier, partly shielding the cancer cells from migrating immune cells, as well as a biochemical microenvironment, that seems to attract and influence immune cell distribution. In addition, stromal targeting by Halofuginone led to an increase in immune cell infiltration. We propose that the here developed model setups will support the understanding of the cellular interplay influencing the recruitment and distribution of immune cells, and contribute to the identification of key players in the PDAC immunosuppressive TME as well as support the discovery of new strategies to treat this immune unresponsive tumor.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda